Tong Ren Tang Technologies' (HKG:1666) attributable profit fell 12% to 521.8 million yuan in 2024 from 590.2 million yuan in 2023, according to a Friday filing with the Hong Kong bourse.
Earnings per share at the traditional Chinese medicine company decreased to 0.41 yuan from 0.46 yuan in the previous year.
Revenue grew 7.2% to 7.26 billion yuan from 6.77 billion yuan a year earlier.
The company declared a final dividend of 0.18 yuan per share, similar to last year's dividend. The dividend will be paid on Aug. 11.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。